Journal article

Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Reilly, J., McMullin, M., Beer, P., Butt, N., Conneally, E., Duncombe, A., Green, A., Mikhaeel, G., Gilleece, M., Knapper, S., Mead, A., Mesa, R., Sekhar, M., & Harrison, C. (2014). Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012. British Journal of Haematology, 167(3), 418–420.

MLA Style

Reilly, J., et al. “Use of JAK Inhibitors in the Management of Myelofibrosis: a Revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.” British Journal of Haematology, vol. 167, no. 3, 2014, pp. 418–20.

Chicago Style

Reilly, J, M McMullin, P Beer, N Butt, E Conneally, A Duncombe, A Green, et al. 2014. “Use of JAK Inhibitors in the Management of Myelofibrosis: a Revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.” British Journal of Haematology 167 (3): 418–20.
Share
Print

Access Document

Publisher copy:: 10.1111/bjh.12985

Authors

+ Reilly, J More by this author

Role:: Author

+ McMullin, M More by this author

Role:: Author

+ Beer, P More by this author

Role:: Author

+ Butt, N More by this author

Role:: Author

+ Conneally, E More by this author

Role:: Author

More authors...

Journal:: British journal of haematology More from this journal
Volume:: 167
Issue:: 3
Pages:: 418-420
Publication date:: 2014-11-01
DOI:: 10.1111/bjh.12985
EISSN:: 1365-2141
ISSN:: 0007-1048

Language:: English
Keywords:: Anemia

Symptom Assessment

Janus Kinase 1

Humans

Pyrazoles

Janus Kinase 2

Splenomegaly

Primary Myelofibrosis

Recurrence

Thrombocytopenia

Maximum Tolerated Dose

Protein Kinase Inhibitors
Pubs id:: pubs:474966
UUID:: uuid:b6c9ea90-9103-4a64-8793-27efd84d50e7
Local pid:: pubs:474966
Source identifiers:: 474966
Deposit date:: 2014-07-10

Terms of use

Copyright date:: 2014

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP